SG11201700122TA - Pharmaceutical compound comprising 13 glycerides, formulation and application thereof - Google Patents
Pharmaceutical compound comprising 13 glycerides, formulation and application thereofInfo
- Publication number
- SG11201700122TA SG11201700122TA SG11201700122TA SG11201700122TA SG11201700122TA SG 11201700122T A SG11201700122T A SG 11201700122TA SG 11201700122T A SG11201700122T A SG 11201700122TA SG 11201700122T A SG11201700122T A SG 11201700122TA SG 11201700122T A SG11201700122T A SG 11201700122TA
- Authority
- SG
- Singapore
- Prior art keywords
- glycerides
- formulation
- application
- pharmaceutical compound
- pharmaceutical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 125000005456 glyceride group Chemical group 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410342799.2A CN105267197B (en) | 2014-07-18 | Pharmaceutical composition, preparation and application thereof containing 13 kinds of glyceride | |
| PCT/CN2015/084295 WO2016008441A1 (en) | 2014-07-18 | 2015-07-17 | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201700122TA true SG11201700122TA (en) | 2017-03-30 |
Family
ID=55073638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700122TA SG11201700122TA (en) | 2014-07-18 | 2015-07-17 | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9585858B2 (en) |
| EP (1) | EP3153163B1 (en) |
| JP (1) | JP6473801B2 (en) |
| KR (1) | KR20170031146A (en) |
| AP (1) | AP2017009706A0 (en) |
| AU (1) | AU2015291530B2 (en) |
| CA (1) | CA2954792C (en) |
| DK (1) | DK3153163T3 (en) |
| EA (1) | EA033077B1 (en) |
| NZ (1) | NZ726582A (en) |
| PL (1) | PL3153163T3 (en) |
| SG (1) | SG11201700122TA (en) |
| WO (1) | WO2016008441A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6113133B2 (en) * | 2014-11-06 | 2017-04-12 | 日本メナード化粧品株式会社 | Stem cell undifferentiated state maintenance agent and growth promoter |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH30249A (en) * | 1992-09-16 | 1997-02-05 | Zhejiang Provincial Hospital O | Neutral lipids from endosperm of job's tears |
| CN1029293C (en) * | 1993-01-01 | 1995-07-12 | 浙江省中医院 | Coix seed neutral oil emulsion |
| CN1029662C (en) * | 1992-09-17 | 1995-09-06 | 李大鹏 | Job's tear seed neutral fat and extracting method |
| JP2002212586A (en) * | 2001-01-19 | 2002-07-31 | Kanegafuchi Chem Ind Co Ltd | Method for refining oil and fat |
| CN1200995C (en) * | 2002-09-28 | 2005-05-11 | 李大鹏 | Method for extracting coarse oil from coix seed with hypercritical carbon dioxide |
| CN1234828C (en) * | 2002-11-21 | 2006-01-04 | 上海高科联合生物技术研发有限公司 | Process for extracting coix seed oil by using supercritical CO2 extraction method |
| CN1778380A (en) * | 2004-11-23 | 2006-05-31 | 乔志亚生技股份有限公司 | Extraction of Job's tears seeds, its component and curative effect |
| CN101036761B (en) * | 2007-04-23 | 2010-05-19 | 肖志勇 | Process for preparing coix seed oil |
| CN101940738A (en) * | 2010-07-27 | 2011-01-12 | 辽宁中医药大学 | Coix seed anticancer Chinese medicament and preparation method thereof |
| CN102177978B (en) * | 2011-04-14 | 2013-01-30 | 西南大学 | Coix seed bran and use thereof |
| US20140370129A1 (en) * | 2013-06-14 | 2014-12-18 | Zhejiang Kanglaite Group Co., Ltd. | Dosing regimen and method for treating cancer using a coix seed oil emulsion |
| CN104173824B (en) * | 2014-07-18 | 2017-02-15 | 浙江康莱特集团有限公司 | Coix seed oil containing 8 triglycerides as well as preparation and application of coix seed oil |
-
2015
- 2015-06-08 US US14/733,098 patent/US9585858B2/en active Active
- 2015-07-17 PL PL15821314T patent/PL3153163T3/en unknown
- 2015-07-17 AP AP2017009706A patent/AP2017009706A0/en unknown
- 2015-07-17 SG SG11201700122TA patent/SG11201700122TA/en unknown
- 2015-07-17 CA CA2954792A patent/CA2954792C/en active Active
- 2015-07-17 EA EA201790117A patent/EA033077B1/en not_active IP Right Cessation
- 2015-07-17 EP EP15821314.0A patent/EP3153163B1/en active Active
- 2015-07-17 DK DK15821314.0T patent/DK3153163T3/en active
- 2015-07-17 NZ NZ726582A patent/NZ726582A/en unknown
- 2015-07-17 AU AU2015291530A patent/AU2015291530B2/en active Active
- 2015-07-17 WO PCT/CN2015/084295 patent/WO2016008441A1/en active Application Filing
- 2015-07-17 KR KR1020177001303A patent/KR20170031146A/en active Search and Examination
- 2015-07-17 JP JP2017503156A patent/JP6473801B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ726582A (en) | 2018-06-29 |
| CA2954792A1 (en) | 2016-01-21 |
| US9585858B2 (en) | 2017-03-07 |
| CA2954792C (en) | 2019-10-29 |
| EP3153163A1 (en) | 2017-04-12 |
| EP3153163B1 (en) | 2019-05-22 |
| PL3153163T3 (en) | 2019-11-29 |
| EP3153163A4 (en) | 2017-05-17 |
| DK3153163T3 (en) | 2019-08-12 |
| JP6473801B2 (en) | 2019-02-20 |
| JP2017524697A (en) | 2017-08-31 |
| WO2016008441A1 (en) | 2016-01-21 |
| AU2015291530B2 (en) | 2018-03-15 |
| CN105267197A (en) | 2016-01-27 |
| KR20170031146A (en) | 2017-03-20 |
| AU2015291530A1 (en) | 2016-12-08 |
| EA201790117A1 (en) | 2017-07-31 |
| EA033077B1 (en) | 2019-08-30 |
| AP2017009706A0 (en) | 2017-01-31 |
| US20160015672A1 (en) | 2016-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251153A1 (en) | Pharmaceutical composition and application thereof | |
| IL271226A (en) | Pharmaceutical formulation | |
| IL252897A0 (en) | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | |
| PT3426294T (en) | Pharmaceutical formulation | |
| IL248785B (en) | N-[1,5-dimethyl-3-oxo-(2,3-dihydro-1h-pyrazol-4-yl)]-4-methyl-isoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising said derivatives | |
| PT3202759T (en) | Alpha-aminoamide derivative compound and pharmaceutical composition comprising same | |
| IL253177A0 (en) | Pharmaceutical formulation | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| HK1245653A1 (en) | Pharmaceutical formulation | |
| IL266537A (en) | Pharmaceutical formulation | |
| ZA201807851B (en) | Pharmaceutical formulation | |
| HK1245113A1 (en) | Pharmaceutical compositions and use thereof | |
| FI3601277T3 (en) | Pharmaceutical formulation | |
| IL275144A (en) | Pharmaceutical formulation | |
| GB201511246D0 (en) | Pharmaceutical formulation | |
| SG11201700122TA (en) | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof | |
| PL3424500T3 (en) | Pharmaceutical composition comprising famitinib | |
| GB201719873D0 (en) | Pharmaceutical formulation |